FDA
-
-
-
-
-
-
-
InMed Provides Update on Pharmaceutical Development Programs - Advancing Lead Drug Candidates Towards IND and Clinical Trial
-
-
-
-
-
-
-
InMed Provides Business Update and Milestones for 2023
-
-
-
-
-
-
-
InMed Pharmaceuticals Inc. (INM) Reports Q2, Provides Business Update
-
-
-
-
-
-
-
InMed Pharmaceuticals Inc. (INM) Reports Submission of Clinical Trial Applications to Evaluate INM-755 (Cannabinol) Cream in a Phase 2 Trial for Epidermolysis Bullosa
-
322,520 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

